Browse
Submit Data
Databases
API
Help

Dataset Information

26 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3,4-Dinitro-1H-pyrazole benzene 0.25-solvate.

ABSTRACT: The asymmetric unit of the title compound, 4C(3)H(2)N(2)O(4)·C(6)H(6), contains two independent dinitro-pyrazole mol-ecules and half a benzene solvent mol-ecule, which lies on a crystallographic inversion centre. Each pyrazole ring is essentially planar (mean deviations of 0.009 and 0.002?Å), with the two nitro groups rotated out of the plane [dihedral angles = 11.7?(2)/31.1?(1) and 21.8?(2)/25.0?(1)° for the two mol-ecules].

SUBMITTER: Li YX

PROVIDER: S-EPMC3120617 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3,4-Dinitro-1H-pyrazole benzene 0.25-solvate.

Li Yong-Xiang YX Du Shan S Wang Jian-Long JL

Acta crystallographica. Section E, Structure reports online 20110511 Pt 6

The asymmetric unit of the title compound, 4C(3)H(2)N(2)O(4)·C(6)H(6), contains two independent dinitro-pyrazole mol-ecules and half a benzene solvent mol-ecule, which lies on a crystallographic inversion centre. Each pyrazole ring is essentially planar (mean deviations of 0.009 and 0.002 Å), with the two nitro groups rotated out of the plane [dihedral angles = 11.7 (2)/31.1 (1) and 21.8 (2)/25.0 (1)° for the two mol-ecules]. ...[more]

PMID: 21754761

Similar Datasets

1-(2,4-Dinitro-phen-yl)-5-ferrocenyl-3-methyl-1H-pyrazole.

Project description:In the title compound, [Fe(C(5)H(5))(C(15)H(11)N(4)O(4))], the dinitro-phenyl and cyclo-penta-dienyl rings make dihedral angles of 53.61 (6) and 23.11 (9)°, respectively, with the pyrazole unit. The two cyclo-penta-dienyl rings are in an eclipsed conformation. The crystal structure is stabilized by inter-molecular C-H⋯O inter-actions, which link mol-ecules into chains parallel to the b axis.

| S-EPMC2960418 | biostudies-literature

1-(2,4-Dinitro-phen-yl)-3-phenyl-4-phenyl-sulfanyl-1H-pyrazole.

Project description:In the title mol-ecule, C(21)H(14)N(4)O(4)S, the pyrazole ring forms dihedral angles of 45.6?(1), 87.7?(1) and 27.4?(1)° with the phenyl, sulfur-substituted benzene and nitro-substituted benzene rings, respectively. In the crystal, mol-ecules are connected by weak C-H?O and C-H?N hydrogen bonds into layers parallel to (010).

| S-EPMC3470205 | biostudies-literature

1-(2,4-Dinitro-phenyl)-3-(4-methyl-phenyl)-4-phenyl-sulfanyl-1H-pyrazole.

Project description:In the title compound, C(22)H(16)N(4)O(4)S, the dihedral angles between the pyrazole ring and the pendant aromatic rings are 26.2 (1), 41.1 (1) and 89.5 (1)°. In the crystal structure, an intermolecular C-H⋯N bond helps to establish the packing. A short C⋯C contact of 3.110 (12) Å is observed between the C atom of the pyrazole CH group and one of the α-C atoms of the 4-methyl-phenyl ring.

| S-EPMC2959740 | biostudies-literature

8-{1-[(4'-Fluoro-[1,1'-biphen-yl]-4-yl)meth-yl]piperidin-4-yl}-3,4-di-hydro-quinolin-2(1H)-one chloro-form 0.25-solvate.

Project description:In the asymmetric unit of the title compound, C27H27FN2O·0.25CHCl3, there are two independent mol-ecules (A and B) together with a partially disordered chloro-form mol-ecule situated about an inversion center. The conformation of the two mol-ecules is very similar. The bridging piperidine rings each have a chair conformation while the piperidin-2-one rings of the quinoline moiety have screw-boat conformations. The benzene rings of the biphenyl moiety are inclined to one another by 26.37 (4) and 23.75 (15)° in mol-ecules A and B, respectively. The mean plane of the central piperidine ring [r.m.s. deviation = 0.241 (2) Å in both mol-ecules A and B] is inclined to the benzene ring of the quinoline moiety by 80.06 (4) in A and 83.75 (15)° in B, while it is inclined to the adjacent benzene ring of the biphenyl group by 73.623 (15) in A and 75.65 (14)° in B. In the crystal, individual mol-ecules are linked by pairs of N-H⋯O hydrogen bonds, forming A-A and B-B inversion dimers with R 2 (2)(8) ring motifs. The dimers are stabilized by C-H⋯O hydrogen bonds and linked via C-H⋯F and C-H⋯N hydrogen bonds into a three-dimensional network. Several C-H⋯π inter-actions are also present.

| S-EPMC3998275 | biostudies-literature

1-(1H-Benzimidazol-2-yl)-4-nitro-benzene dimethyl-formamide solvate.

Project description:In the title compound, C(13)H(9)N(3)O(2)·C(3)H(7)NO, the benzimidazole ring system and the benzene ring are essentially coplanar, forming a dihedral angle of 0.86?(5)°. The crystal packing is stabilized by an inter-molecular N-H?O hydrogen bond and a ?-? stacking inter-action with a centroid-centroid separation of 3.685?(4)?Å.

| S-EPMC2968547 | biostudies-literature

4-(3,4-Diacetyl-5-methyl-1H-pyrazol-1-yl)benzene-sulfonamide.

Project description:In the title mol-ecule, C(14)H(15)N(3)O(4)S, the pyrazole ring is aligned at a dihedral angle of 55.5 (1)° with respect to the benzene ring; the mean planes of the acetyl substituents are twisted by 13.4 (3) and 30.1 (3)° with respect to the pyrazole ring. Inter-molecular classical N-H⋯O and weak C-H⋯O hydrogen bonding links the mol-ecules, forming a three-dimensional network architecture in the crystal structure.

| S-EPMC3052070 | biostudies-literature

6-Fluoro-1,3,4-triphenyl-1H-pyrazolo[3,4-b]quinoline benzene hemisolvate.

Project description:In the title compound, C(28)H(18)FN(3)·0.5C(6)H(6), the 1H-pyrazolo[3,4-b]quinoline core is almost planar (r.m.s = 0.0371 Å, maximum deviation = 0.0571 Å) and aromatic. The solvent benzene mol-ecules are located around inversion centres. In the crystal, mol-ecules related by centres of symmetry form dimers, with distances of 3.932 (3) Å between best planes through the fused core due to π⋯π stacking. The phenyl substituents at positions 1, 3 and 4, are twisted away from the core, making dihedral angles of 29.66 (7), 44.59 (7) and 67.94 (6)°, respectively.

| S-EPMC2983603 | biostudies-literature

3,5-Bis(2,4-dinitro-phen-yl)-4-nitro-1H-pyrazole acetone monosolvate.

Project description:The title structure, C(15)H(7)N(7)O(10)·C(3)H(6)O, was prepared by penta-nitration of 3,5-diphenyl-1H-pyrazole. The proton attached to a pyrazole N atom forms a hydrogen bond with the O atom of the acetone solvent mol-ecule, owing to the NO(2) enhanced acidity of the proton. The NO(2) group on the phenyl C atom is twisted by 33.9?(2)° from coplanarity with the ring in order to avoid a short intra-molecular O?O contact with an O atom of an adjacent pyrazole-bonded NO(2) group.

| S-EPMC3275082 | biostudies-other

2,4-Dinitro-1-phenoxy-benzene.

Project description:The title compound, C(12)H(8)N(2)O(5), was obtained by the reaction of 1-chloro-2,4-dinitro-benzene and phenol in the presence of potassium carbonate. The nitro-substituted benzene ring lies on a mirror plane, with one NO(2) group in the same plane and the other disordered across this plane. The phenoxy-benzene unit is placed perpendicular to this mirror, resulting in an exact orthogonal relationship between the phenyl and benzene rings in the mol-ecule. The crystal packing exhibits no significantly short inter-molecular contacts.

| S-EPMC2979788 | biostudies-literature

2,5-Dimethyl-1,3-dinitro-benzene.

Project description:The title compound, C(8)H(8)N(2)O(4), was prepared via the nitration of p-xylene. The mol-ecules are stacked along the c axis in an antiparallel manner. The two nitro groups are rotated relative to the benzene ring with dihedral angles of 44.50 (7) and 31.67 (8)°. The tilt of the nitro groups allows the formation of C-H⋯O inter-actions between the ring C-H and nitro groups of adjacent mol-ecules creating puckered sheets perpendicular to the c axis. The H atoms of the methyl group in the 5-position are disordered (60° rotation) with an occupancy of 0.616 (19) for the major component. The crystal was found to be a non-merohedral twin with a twin law [-1 -0.002 0.005, 0.00031 -1 0.002, 0.118 -0.007 1] corresponding to a rotation of 180° about the reciprocal axis (001) and refined to give a minor component fraction of 0.320 (2).

| S-EPMC3200820 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data